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Rehabilitative intervention during and after pediatric hematopoietic stem cells 
transplantation: an analysis of the existing literature. 
 
Abstract 
Hematopoietic Stem Cell Transplantation (HSCT) is a therapeutic strategy for several onco-
haematological diseases. It greatly increases long-term survival rates but growths the incidence of 
related-effects on physical, neuropsychological and functional functioning with negative impact on 
of quality of life (QoL).	  
The objective of this paper was to summarize and compare the existing literature focused on physical 
exercise interventions among pediatric HSCT recipients to explore the most employed rehabilitative 
assessment and treatment tools.	  
Relevant studies published up to April 1, 2015 were selected from PudMed, The Cochrane Library, 
CINAHL, Scopus, PEDro and PsycINFO: 10 studies with different research types were included. 
Proposed rehabilitative interventions was performed before, during, and after infusion. In this paper, 
we subdivided articles on the base of moment of intervention in the course of transplant process 
(during hospitalization and after discharge) dedicating a paragraph to studies focused on management 
of cGVHD.  
A previous literary review has already shown that rehabilitation programs improve physical fitness 
and functional abilities with a positive influence on (QoL). Thanks to our analysis, we could identify 
some significant outcome variables and shared intervention areas suitable for clinical practice and 
trials design. In fact, further studies are required for validation of rehabilitative guidelines. 
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Introduction	  
Hematopoietic stem cell transplantation (HSCT) involves intravenous infusion of autologous or 
allogeneic stem cells collected from bone marrow, peripheral blood, or umbilical cord blood preceded 
by high-dose chemotherapy and, if appropriate total-body irradiation, to re-establish hematopoietic 
function in patients whose immune system is damaged or defective(1). HSCT is a potential curative 
option for many diseases, such as hematologic malignancies and refractory solid tumors. This 
procedure led to considerable improvement in survival rates, but also determined the onset of late 
effects-related problems(2–10). Due to the severity of conditioning regimen, length of isolation and 
bed rest period, immunosuppression and drug toxicities, it seriously impairs children’s physical 
functioning. HSCT recipients may suffer impairments in cardiorespiratory fitness (with high 
incidence of severe fatigue), muscle trophysm and strength, immunologic recovery (with high risk of 
infections), functional abilities and autonomy(3–5,11). These elements determine an undeniable 
decline of quality of life (QoL) in pediatric cancer survivors(12–15). In addition, graft versus host 
disease (GVHD) is a frequent complication of allo-HSCT(16). The incidence of the chronic form 
(cGVHD) has been estimated between 30-70% in those surviving beyond 100 days, with an average 
onset of 4-6 months after transplant. cGVHD symptoms, such as gradual loss of lung function, loss 
of flexibility and strength, very weak state of health, articular angle reduction, low functional abilities, 
cause a vicious circle that induces immobility with a consequent deterioration of physical 
functioning(17–21).	  
Some studies have already shown the feasibility, safety and effectiveness of a rehabilitative program 
during and after HSCT’s period (22–27) but they very heterogeneous in terms  of  kind of study, 
outcome measures, rehabilitative assessments tools and treatment programs. A recent review, 
conducted by West et al., 2014(27), focused on impact of exercise programs on physical activity in 
this population, concluded that exercise as medicine in a non-invasive and non-pharmaceutical 
treatment that may be used in management of physical morbidity but exercise prescription guidelines 
are needed.  According to these conclusions, we conducted a literature analysis focusing on 
intervention programs and proposed instruments for rehabilitative assessment and treatment. The aim 
was to synthesize knowledge and author operating tips diversifying them by the moment of 
intervention: during hospitalization (in-patients intervention) and after discharge (out-patients 
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intervention). We hope to establish expendable guidelines for clinical practice and for further studies 
about physical exercise among children and adolescents treated with HSCT.  
	  
Methods	  
This paper included studies on rehabilitative assessment and treatment of children undergoing HSCT 
for the treatment of different onco-haematological diseases. Studies were chosen considering as 
inclusion criteria: published until April 1, 2015; involving patients aged 0-18 years; focused on 
rehabilitative assessment and/or treatment of HSCT effects; published in English. 	  
Relevant studies were identified conducting research on 6 biomedical databases: PubMed, The 
Cochrane Library, CINAHL, Scopus, PsycInfo and PEDro. In order to compose the research array, 
the primary search terms “Hematopoietic stem cell transplantation”, “ Pediatric Hematopoietic stem 
cell transplantation”, “Graft versus host disease”, were combined with the following key words 
“Outcomes”, “Late effects”, “Physical assessment”, “Functional assessment”, Exercise”, 
“Rehabilitation”,  “Motor rehabilitation”, “Physical activity” (Mesh terms or free-text words). Some 
example of full search strategy were: “ Hematopoietic stem cell transplantation AND Exercise (Limit: 
all child)”, “Graft versus host disease AND rehabilitation (Limit: all child)”. No mesh terms have 
been used: they seem to be not useful if the argument of research has not a wide literature. 	  
We obtained a recent review(26) involving adults HSCT recipients and took this review as an example 
for conducting the present research.  
Ten studies met the inclusion criteria and were further subdivided into articles focus on: in-patients 
intervention (beginning at child hospitalization for conditioning therapy and continuing until 
discharge); out-patients intervention (beginning at discharge and continuing until the end of the first 
year after transplant); assessment and treatment of Chronic Graft versus Host Disease. 
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Selected studies analysis	  
In-patients phase: rehabilitative assessment and treatment.	  
Currently, scientific literature presents 3 studies on exercise programs during hospitalization: 
Chamorro-Vina et al., 2012(28), Rosenhagen et al.,2011(25), Chamorro-Vina et al., 2010(24). 
They are a randomized clinical trial (RCT), a controlled clinical trial and a case-control study.  
Chamorro-Vina et al., 2012 had the objective of evaluating effects of an exercise program during 
both in-patients and out-patients phases on immune recovery and on prevention of QoL and physical 
fitness decline. The sample included 24 patients (5-18 years) undergoing auto-HSCT.	  
Outcome variables were measured at baseline, + 30 days from transplant, + 85, + 180 days. These 
were: quantitative and functional immune recovery; body mass index (BMI); nutrition; cardio-
vascular functioning; QoL; fatigue; physical activity levels; motor skills; muscle resistance; strength;  
muscle elasticity.  
Exercise intervention during the in-patient phase (30 days) included aerobic activities and resistance 
training, consisting in muscle strengthen exercises involving major muscle groups. The out-patients 
phase intervention will be exposed in the next session of the paper.  
Results have not been published yet. 
 
Rosenhagen at al., 2011 had the purpose of assessing feasibility and patient acceptance of supportive 
physical therapy into isolation phase of PSCT. Their sample included 23 patients (15.3 +/-3.7 years) 
undergoing auto/allo-PBSCT. 13 of 23 patients were assigned to intervention group, 10 to the control 
group.	  
Outcomes variables were evaluated at recruitment moment and after discharge. These were: motor 
skills, health-related quality of life (HRQOL); fatigue; acceptance of training intervention. 
Intervention program involved the in-patients phase (average of 34 days). Sessions were divided in: 
endurance training (10 minutes) using a stationary bicycle ergometer, strength training, including 
exercises with balls, and coordination exercises.  
Results of the study demonstrate the feasibility of an exercise intervention during in-patients phase. 
Acceptance for proposed program was high, too. Authors showed that ergometer training lead to 
stabilization or even a slight improvement of physical performance with a higher VO2max and a lower 
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resting heart rate. Moreover, decline of manual force could be prevented. Implemented physical 
activity also leads to progress in QoL and cancer-related fatigue; ultimately, it helps children to trust 
in their physical abilities, enabling them to regain movement skills earlier in the phase of 
rehabilitation and keeps strength and endurance during the isolation phase on a functional level. 
	  
Chamorro-Vina et al., 2010 had the objective of evaluating the effects of a 3 weeks-rehabilitative 
intervention performed during inpatient stay for HSCT on immune cell recovery and on physical 
fitness. Their sample included 7 patients (4-16 years) undergoing allo-HSCT. The control group 
included 13 patients (7 +/- 3 years) following the same transplant protocol. Outcome variables 
measured before, 15 and 30 days after HSCT, were: immune recovery, BMI and fat-free mass (FFM). 
Intervention program started at the beginning of conditioning phase and lasted until the end of 
neutropenic phase (about 3 weeks). The treatment was subdivided in 5 session with the following 
organization: articular motion and stretching exercise at the beginning/end of each session; aerobic 
training with low to moderate cycle ergometer (25-30 mins) and strength exercise engaging the 
majority muscle groups performing on set of 12-15 repetitions.   
The results of the study showed that exercise interventions in in-patients did not negatively affect 
immune cell recovery. Moreover, referred effects on anthropometric variables contributed to increase 
the patient’s body mass, BMI and fat-free-mass. Training program improved children’s functional 
capacity, that increased over intervention period. 
 
	  
Out-patients phase: rehabilitative assessment and treatment.	  
Three studies refer to post-transplant phase: Chamorro-Vina et al.,2012(28), San Juan et al., 
2008(29), Hayes et al.,2004(30). The first is a RCT, the other are clinical trials.  
First part of Chamorro-Vina et al., 2012 was already exposed in the previous paragraph. The out-
patients intervention (10 weeks after discharge) consisted of 2 unsupervised weekly/sessions and 1 
supervised home-based training.  Supervised session was similar to in-patient intervention consisting 
of combined aerobic, resistance and strength training; the last involved the major muscle groups with 
12-15 repetitions for each exercise set. Home-based program included 20-30 minutes of aerobic 
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exercises and 30 minutes of strength and stretching exercise using Nintendo Wii devices. Training 
adherence were reported in a logbook. Results have not been published yet. 
 
The purpose of San Juan et al., 2008 was to determine if eight-week intrahospital supervised 
program improves functional capacity and QoL in children HSCT recipients. Sample included 8 
patients (8-16 years) who received haploidentical or allo-HSCT in the last 2-12 months; 8 healthy 
children were selected as a group control. 
Outcome variables, evaluated before and after intervention, were: VO2peak and ventilator threshold; 
gas-exchange-data; strength; resistance; functional mobility; passive and active ankle dorsiflexion; 
QoL. 
Exercise program (8 weeks) begun in a range of 2-12 months after transplant. Sessions started and 
ended with a low intensity 15-min warm up and cool-down period consisting of cycle ergometer 
7edaling and stretching exercises (8-15 repetitions). Training was divided into aerobic and strength 
exercises. The first consisted of 7edaling on a cycle ergometer, running, walking and aerobic games 
(group activities, exercise with ball…).  Patients started with 10 min of aerobic exercises at 50% age-
predicted maximum heart rate and progressed to 30 min of continuous exercise at ≥ 70% HRmax. 
Stregth training included 11 exercises engaging the major muscle groups on set of 8-15 repetitions.  
As a result, improvements in VO2peak values was found; this data is an indicator for health status and 
predictor of mortality. Significant training-induced improvements have been found in tests on 
functional abilities. Authors obtained enhancement in children’s and parent’s self-reported QoL, too. 
They underlined the need of performing individually supervised training programs instead of home-
based training and the importance of including both aerobic and resistance exercises. 
 
Hayes et.al, 2004 had the aim of evaluating the impact of HSCT on QoL and determining the effect 
of a mixed type, moderate intensity exercise program on QoL. The sample included 12 patients (16-
64 years) undergoing auto-HSCT. During the first and the second phase all patients were considered 
to be in the same group; in the third phase patients were allocated to the control-stretching group and 
to the intervention group. 
Outcome variables, evaluated 7-10 days before admission for the high dose chemotherapy regimen, 
the day after infusion and after 3 months was : QoL and	  peak aerobic capacity.  
8	  
	  
Intervention group followed a rehabilitation program (12 weeks) consisting of aerobic and resistance 
exercises. Aerobic component involved a combination of treadmill, walking and stationary cycling 
(3 times per week, for 20-40 minutes). Intensity and duration of exercises gradually increased. 
Machine weights used for resistance-training was set to induce failure between 15 and 20 repetitions 
during weeks 1-6, followed by 8-12 repetitions during 7-12 weeks. All patients kept physical activity 
logbooks. 	  
As a result, this study demonstrated statistically and clinically significant improvements in all 
measures of QoL. Moreover, peak aerobic capacity seems to be associated with global and physical 
functioning and QoL: higher levels of fitness cause higher QoL.  
 
Assessment and treatment of cGVHD. 
Selected articles regarding cGVHD were 4: 2 of them investigates the role of rehabilitative 
intervention: Carenzio et al., 2007(18)  and Currie et al., 2002(19). They are both case-reports. The 
other were observational studies concern the validation of motor abilities assessment tools in pediatric 
patients affected by cGVHD: Pidala et al., 2013 (31) and L. Li et al, 2008(32). 	  
Carenzio et al., 2007 was aimed at evaluating clinical and functional assessment and results obtained 
following rehabilitative treatment in children affected by cGVHD. It presents 6 case-reports of 
patients (8-17 years) affected by HSCT-related cGVHD. Clinical and functional assessment, 
performed prior to rehabilitative treatment, after 6 and 12 months, included these outcome variables: 
range of movement (ROM), extension of skin graft, localization of ulcers, functional abilities and 
spirometry. 	  
The rehabilitative intervention (1 year)involved: stretching and weight-bearing exercises; exercises 
to improve change of body position and postural control; massotherapy; occupational therapy; 
stroking and friction massage for skin adhesions and skin stretching; chest therapy for increase thorax 
expansion and bronchial clearance.  
Results refer that physical conditions improved in 3 cases, remained stationary in 2 cases and 
worsened in 1 case. Patients showed improvements in functional abilities; rehabilitation favored 
school return and socialization and the collaboration of child’s parents appeared fundamental in 
home-training. Authors concluded that cGVHD needs rehabilitation at onset of first cutaneous signs. 
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Currie et al, 2002 had the aim to report results of a topical treatment of sclerodermoid cGVHD and 
comment on the rationale of its treatment program. Authors explain the case-report of a 14-year-old 
girl affected by sclerodermoid cGVHD onset more than 1 year after allo-HSCT. The rehabilitative 
assessment, continuously performed during intervention, included as outcome variables: ROM (arms 
and legs), evaluation of skin condition and assessment of functional abilities. The rehabilitative 
treatment consisted of:	   topical treatment of skin lesions with application of paraffin baths at a 
temperature of 48° at the beginning of each session; physical therapy (mobilization, stretching) for 
improving ROM;	  strength training;	  occupational therapy;	  parent’s training of exercise program and 
use of paraffin. As a result, treatment brought improvements in ROM, skin condition and functional 
abilities.  Authors underlined the importance of physical and occupational therapy with paraffins bath 
early in the treatment so that more severe impairments could be prevented.  
Pidala et al., 2013 had the objective of examining recommended functional measures, 2 Minute Walk 
Test (2MWT) and Hand Grip Strength Test (HGS), among cGVHD-affected HSCT recipients to 
determine their association with patient-reported measures, cGVHD severity, response and mortality. 
The sample of the study involved 584 patients (2-79 years) who undergone allo-HSCT. They were 
divided into incidence (enrolment <3months after cGVHD diagnosis) and prevalent (enrolment 
≥3months after cGVHD diagnosis but <3 years after HSCT) cases. Only 14 patients were children. 
Outcome measures included: cGVDH symptoms; energy expenditure and physical fitness; QoL; 
physical functioning. 
In the assessment of HGS, strength was measured 3 times from the dominant hand using portable 
electronic dynamometer. In the conduct of the 2MWT the patient walked 50-foot course, and the total 
distance covered in 2 minutes was recorded.  
Results showed an independent association of the 2MWT with mortality of cGVHD affected patients. 
Impaired 2MWT was significantly associated with higher symptoms burden, impaired QoL, 
functional disability (assessed by the HAP(33–35)) and increased mortality. Data largely did not 
support the importance of HGST even if a link with some QoL domains has been found.	  
	  
L. Li et al., 2008 was aimed to determine the validity of the 2MWT as a measure of exercise tolerance 
and physical performance in patients with cGVHD. Only the congress’poster of the study was 
available and it did not specify the age of the 51 patients involved.	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Adopted outcome measures consisted of: distance walked in 2 and 6 minutes; physical functioning; 
energy expenditure and physical fitness; cGVDH symptoms and global severity. 	  
As a result, 2MWT showed strong positive correlation with 6MWT, SF-36(36)and HAP(37). Authors 
concluded that 2MWT and 6MWT (38)could be used interchangeably in patients with cGVHD. 
 
Discussion 
The paper summarized and critically evaluated rehabilitative assessment and treatment tools currently 
used in HSCT pediatric patients. Ten eligible studies were found: 3 regarding in-patient phase, 1 
referring both to in-patient and out-patient phase, 2 about out-patients phase and 4 which connected 
to cGVHD. One review referring both to in-patient and out-patient phase has been selected too.  
Referring to in-patients phase, 2/3 studies chose as outcomes measures QoL, functional motor 
abilities and fatigue. Fatigue was evaluated in all studies through the PedsQL Multidimensional 
Fatigue Scale(39) (Table1).  
About intervention programs, 2/3 suggested 5 weekly sessions each with a duration of 50 minutes. 
Endurance and strength training were proposed by 3/3 studies and aerobic activities by 2/3 (Table2). 
 
All articles regarding out-patients phase considered HRQOL as an outcome measures. 2/3 studies 
chose as other outcomes measures muscle resistance and strength, cardiovascular functioning and 
gas-exchange-data. Functional motor abilities and VO2peak were investigated in 2/3 and common tests 
ware used: respectively Time Up and Go (TUG) ,Time Up and Down Stairs Test (TUDS) (28,29) and 
Treadmill Test (Table3).  
About intervention programs, all studies tested programs with a frequency of 3 weekly session, in 2/3 
each session had a duration of 60 minutes. The three selected areas were the same chose for in-patient 
phase: 3/3 studies proposed aerobic activities and endurance and strength exercises, 2/3 stretching 
exercises. 2/3 study utilized a logbook for patients in order to empower them and increase their 
participation to rehabilitation program (Table4). 
 
All studies on cGVHD individuated as outcome variables physical functioning, 2/4 suggested SF-36 
as evaluation instrument. 3/4 articles investigate cGVHD symptoms and cGVHD global severity, 2/3 
used the Lee cGVHD Symptom Scale(40). Other outcomes measures investigated by 2/4 works were: 
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ROM, mortality, cGVHD response and functional abilities. QoL, energy expenditure, physical fitness 
and strength were evaluated in 2/4 articles using the same tools, respectively: FACT-BMT(41), HAP 
and 2MWT (Table5).  
Intervention program was referred only in 2 studies which agree on stretching exercises and 
occupational therapy, with particular attention for functional abilities, strength and resistance 
training(Table6). 
	  
Conclusion 
In conclusion, rehabilitation programs improve physical morbidity in paediatric HSCT population 
and facilitates reintegration into everyday life (18,24,25,27–29). However, today there is no 
agreement around a most suitable and effective exercise program. First of all, validated assessment 
instruments are needed in order to control outcome variables that are capable of indicating efficacy 
of intervention programs. They are both requested by therapists for everyday clinical practice than by 
scientific literature for clinical trials.  
Regarding exercise interventions, pending further studies, our analysis can be a starting point for the 
formulation of intervention program: most investigated outcome measures were QoL and physical 
functioning and abilities. About rehabilitative intervention, there were heterogeneous data regarding 
duration of intervention and frequency of sessions, otherwise most studies suggested that each 
rehabilitative session has to last about of 60 minutes for 3-5 weekly/sessions. Most suggested 
exercises areas were: aerobic activities, strength training and endurance/resistance training 
accompanied by articular motion and stretching exercises. These matches with Physical Activity 
Guidelines for Americans (42) mentioned by Majhail et al., 2012(43) about management of muscle 
and soft tissue HSCT complications but it’s clear that guidelines need to be adapted and compared 
with scientific literature about HSCT patients whose physical functioning isn’t comparable with that 
of healthy subjects.  
Further studies are strictly necessary to base rehabilitation practice of pediatric HSCT recipients on 
scientific evidence to ensure them a real reintegration into everyday life.  
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